ISSN 1612-3352

Editors in Chief

Prof. Dr. Claus F. Claussen, Neurootological Research Institute of the Research Society for Smell, Taste, Hearing and Equilibrium Disorders at Bad Kissingen (4-G-F). Bad Kissingen, Germany.
Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Production Managers

Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Associated Editors

The editors welcome authors to submit articles for publications in the ASN.

Read the Information for Authors.

Kurhausstraße 12
D-97688 Bad Kissingen
Telefon +49-971-6 4832
Fax +49- 971- 6 8637


Publications by

Ph.D. Barbara A. Goldstein

25 publications on the archives

Final Common Pathway for Tinnitus: Theoretical and Clinical Implications of Neuroanatomical Substrates

A final common pathway (FCP) for tinnitus has been hypothesized since 1989 for all clinical types of tinnitus, particularly subjective idiopathic tinnitus (SIT) of the severe disabling type. This was intended to explain the transformation-transition of the sensation of an aberrant auditory sensation—tinnitus (i.e., the sensory component)—to one of affect (i.e., the emotional-behavioral component) or, […]

Central Nervous System Neurodegeneration and Tinnitus: A Clinical Experience Part II: Translational Neurovascular Theory of Neurodegenerative CNS Disease and Tinnitus

The translation of a neurovascular hypothesis for Alzheimer’s disease to subjective idiopathic tinnitus (SIT) is presented as a challenge to the predominantly sensorineural view of SIT and its clinical application for tinnitus treatment. The concept of neurovascular dysfunction and neurodegeneration (ND) in SIT patients has been proposed and reported as an etiology in a particular […]

Central Nervous System Neurodegeneration and Tinnitus: A Clinical Experience Part I: Diagnosis

CNS Neurodegeneration and Tinnitus IIn an evolving clinical experience since 1979, the medical significance of the symptom of tinnitus has been identified as a “soft” sign of neurodegeneration (ND) in the central nervous system (CNS) in a particular subset of tinnitus patients diagnosed with a predominantly central-type, severe, disabling, subjective idiopathic tinnitus.To highlight this experience, […]

Ultrahigh frequency stimulation tinnitus and audiologic findings pre and post stimulation in 15 patients-long term.

Fifteen subjects with subjective idiopathic tinnitus of the severe disabling type were stimulated twice weekly for either 10, 12 or 14 sessions with the UltraQuiet Therapy. Audiologic testing including comprehensive audiometry and tinnitus testing including outcome determinations, pitch and loudness matching, measurement of residual inhibition, Feldmann masking curves, and the Loudness Discomfort Level test was […]

Outcome determination-update.

Outcome determinations are critical for evaluation of any methods for Tinnitus Targeted Therapy recommended to the tinnitus patient for relief. Multiple parameters of identification will be reviewed for outcome determinations. This update will present the Client Oriented Scale of Impairment (COSI), which has been adapted for use with tinnitus patients. The COSI has revealed significant […]

Tinnitus outcome profile and tinnitus control

This reports recommends the consideration of development of additional outcome measures to be used as a battery of subjective self-assessment questionnaires for patients with tinnitus. The goal is improved overall care for the tinnitus patient. The name of the battery of outcome questionnaires is TOP. Five existing outcome measurements have been incorporated into the profile […]

Quantitative electroencephalography: preliminary report—tinnitus

This preliminary report is an account of 21 consecutive patients who had tinnitus of the severe disabling type and were examined with quantitative electroencephalography (QEEG).

Gaba – benzodiazepine – chloride receptor – targeted therapy for tinnitus control: preliminary report

Our goal was to attempt to establish neuropharmacological tinnitus control (i.e., relief) with medication directed to restoration of a deficiency in the g-aminobutyric acid – benzodiazepine – chloride receptor in tinnitus patients with a diagnosis of a predominantly central type tinnitus.

Measurement of bone conduction levels for high frequencies

For assessment of safety, it is necessary to measure the maximum possible force exerted by a bone conduction device coupled to the human head.



If you are not already registered, please register here for free.

If you are registered but have forgotten your password (or you never had one), click here to recover your password.

Proceedings of



2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |